{
    "nctId": "NCT06491654",
    "briefTitle": "Physiotherapy Program Impact on Breast Cancer-Related Lymphedema",
    "officialTitle": "Effect of a Physiotherapy Program Based on Concurrent Strength and Moderate-to-high Intensity Aerobic Exercise Training, Along With Cohesive Bandaging, in Women With Breast Cancer-related Lymphedema.",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer Related Lymphedema",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 36,
    "primaryOutcomeMeasure": "Molecular variables: proteome.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer survivors who have completed treatment (chemotherapy, surgery, and/or radiotherapy) at least 6 months prior to randomization for the trial.\n* Patients diagnosed with unilateral stage I or II BCRL as established by the International Society of Lymphology Congress Working Group in 2020, or patients at risk of developing unilateral BCRL (who have received radiotherapy in the axillary region/radical mastectomy/modified radical mastectomy and lymph node dissection/breast surgery and sentinel lymph node biopsy).\n* Age between 18 and 65 years.\n* Voluntary participation in the study and informed consent.\n\nExclusion Criteria:\n\n* Recent surgery (\\<3 months) or planned surgery during the study period.\n* Patients with cognitive impairment.\n* Patients with bilateral lymphedema.\n* Health problems or illnesses that prevent them from participating in the intervention.\n* Other serious conditions that may affect their HRQOL (Health-Related Quality of Life).",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}